Preeclampsia and subsequent breast cancer risk

Cancer Causes and Control

Volumn 26, Issue 6, 2015, Pages 955-956

  Carbillon, Lionel ^a   Delahosseraye, Claire ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR; SOMATOMEDIN C RECEPTOR; VASCULOTROPIN A;

ANGIOGENESIS; BLOOD FLOW; BREAST CANCER; CELL DIFFERENTIATION; CELL INVASION; CYTOTROPHOBLAST; DISEASE ASSOCIATION; HUMAN; LETTER; MATERNAL HYPERTENSION; PREECLAMPSIA; PRIORITY JOURNAL; REPRODUCTION; RISK ASSESSMENT; BREAST; BREAST NEOPLASMS; CONGENITAL MALFORMATION; FEMALE; GENETICS; MAMMARY GLAND; PATHOLOGY; PREGNANCY;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MAMMARY GLANDS, HUMAN; PREGNANCY; RECEPTOR, IGF TYPE 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84929990593     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0577-5     Document Type: Letter

References (8)

1. Prebil LA, Ereman RR, Powell MJ (2014) First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes Control 25:859–868
2. Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683
3. Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol. 8:1088–1100
4. Cheng D, Hao Y, Zhou W et al (2013) Vascular endothelial growth factor +936C/T, −634G/C, −2578C/A, and −1154G/A polymorphisms with risk of preeclampsia: a meta-analysis. PLoS ONE 8:e78173
5. Troisi R, Braekke K, Harsem NK et al (2008) Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies. Am J Obstet Gynecol 199:653.e1–653.e10
6. Zhou Y, Genbacev O, Fisher SJ (2003) The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation. Ann N Y Acad Sci 995:73–83
7. Parr C, Watkins G, Boulton M et al (2005) Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer 41:2819–2827
8. Bear HD, Tang G, Rastogi P et al (2012) Bevacizumab added to neoadjuvant chemotherapy for breast cancer. N Engl J Med 366:310–320